These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 28509668)

  • 21. Push-Dose Vasopressin for Hypotension in Septic Shock.
    Nowadly CD; Catlin JR; Fontenette RW
    J Emerg Med; 2020 Feb; 58(2):313-316. PubMed ID: 32173168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose vasopressin in the treatment of septic shock in sheep.
    Sun Q; Dimopoulos G; Nguyen DN; Tu Z; Nagy N; Hoang AD; Rogiers P; De Backer D; Vincent JL
    Am J Respir Crit Care Med; 2003 Aug; 168(4):481-6. PubMed ID: 12791578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock.
    Daley MJ; Lat I; Mieure KD; Jennings HR; Hall JB; Kress JP
    Ann Pharmacother; 2013 Mar; 47(3):301-10. PubMed ID: 23447481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal arterial resistance in septic shock: effects of increasing mean arterial pressure with norepinephrine on the renal resistive index assessed with Doppler ultrasonography.
    Deruddre S; Cheisson G; Mazoit JX; Vicaut E; Benhamou D; Duranteau J
    Intensive Care Med; 2007 Sep; 33(9):1557-62. PubMed ID: 17486316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radial to femoral arterial blood pressure differences in septic shock patients receiving high-dose norepinephrine therapy.
    Kim WY; Jun JH; Huh JW; Hong SB; Lim CM; Koh Y
    Shock; 2013 Dec; 40(6):527-31. PubMed ID: 24089010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
    Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
    Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of vasopressin in septic shock : critical evaluation].
    Gradwohl-Matis I; Brunauer A; Dankl D; Dünser M
    Anaesthesist; 2014 Jun; 63(6):503-10. PubMed ID: 24838480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasopressor use in septic shock: an update.
    Leone M; Martin C
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):141-7. PubMed ID: 18443479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Terlipressin for norepinephrine-resistant septic shock.
    O'Brien A; Clapp L; Singer M
    Lancet; 2002 Apr; 359(9313):1209-10. PubMed ID: 11955542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arginine vasopressin in septic shock: supplement or substitute for norepinephrine?
    Rehberg S; Enkhbaatar P; Traber DL
    Crit Care; 2009; 13(4):178. PubMed ID: 19691818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial.
    Lauzier F; Lévy B; Lamarre P; Lesur O
    Intensive Care Med; 2006 Nov; 32(11):1782-9. PubMed ID: 17019548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock.
    Hammond DA; McCain K; Painter JT; Clem OA; Cullen J; Brotherton AL; Chopra D; Meena N
    J Intensive Care Med; 2019 Oct; 34(10):805-810. PubMed ID: 28618919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasopressor Discontinuation Order in Septic Shock With Reduced Left Ventricular Function.
    Taylor A; Jones T; Forehand CC; Smith SE; Dykes H; Newsome AS
    J Pharm Pract; 2022 Dec; 35(6):879-885. PubMed ID: 33977793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasoactive Agent Use in Septic Shock: Beyond First-Line Recommendations.
    Sacha GL; Bauer SR; Lat I
    Pharmacotherapy; 2019 Mar; 39(3):369-381. PubMed ID: 30644586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock.
    van Haren FM; Rozendaal FW; van der Hoeven JG
    Chest; 2003 Dec; 124(6):2256-60. PubMed ID: 14665508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS).
    Jeon K; Song JU; Chung CR; Yang JH; Suh GY
    Crit Care; 2018 May; 22(1):131. PubMed ID: 29784057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timing of norepinephrine in septic patients: NOT too little too late.
    Rachoin JS; Dellinger RP
    Crit Care; 2014 Dec; 18(6):691. PubMed ID: 25672524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Therapeutic Role of Vasopressin on Improving Lactate Clearance During and After Vasogenic Shock: Microcirculation, Is It The Black Box?
    Barzegar E; Ahmadi A; Mousavi S; Nouri M; Mojtahedzadeh M
    Acta Med Iran; 2016 Jan; 54(1):15-23. PubMed ID: 26853286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing mean arterial pressure in septic shock: a critical reappraisal of the literature.
    Leone M; Asfar P; Radermacher P; Vincent JL; Martin C
    Crit Care; 2015 Mar; 19(1):101. PubMed ID: 25888071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.